Stock Market & Financial Investment News

News Breaks September 19, 2012 06:30 EDT GILD Gilead price target raised to $75 from $68 at Deutsche Bank Deutsche Bank raised its price target for Gilead on expectations higher hepatitis C virus treatments will increase peak sales of the company's GS-7977. The firm expects HCV annual treatments to double in the U.S. from current projections by 2020 and reiterates a Buy rating on shares of Gilead. News For GILD From The Last 14 Days Check below for free stories on GILD the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 20, 2013 07:34 EDT GILD UBS to host a conference Subscribe for More Information May 16, 2013 11:50 EDT GILD Celgene, Gilead lower after new data published at ASCO Subscribe for More Information May 15, 2013 18:32 EDT GILD Gilead announces response data from Phase 2 study of Idelalisib Subscribe for More Information May 13, 2013 09:39 EDT GILD Active equity option families trading Active equity option families trading on open according to Track Data: AAPL C TSLA LVS GILD FSLR Sign up for a free trial to see the rest of the stories you've been missing.